Tezspire Phase III Nasal Polyp Data May Lead To Second Indication

 
• By Joseph Haas
  
AstraZeneca and Amgen hope to file Tezspire for nasal polyps with Phase III readout (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas